Magnetic Resonance Imaging for Prostate Cancer

Phase-Based Progress Estimates
Prostate Cancer+1 MoreMagnetic Resonance Imaging - Procedure
What conditions do you have?

Study Summary

This trial looks at whether 3D MRI is better than standard MRI in finding prostate cancer.

Eligible Conditions
  • Prostate Cancer
  • Prostate Adenocarcinoma

Treatment Effectiveness

Study Objectives

2 Primary · 0 Secondary · Reporting Duration: through study completion, an average of 1 year

Year 1
The change in the image quality of the novel dimensions
To be assessed with scoring of quantitative image metrics in regions of prostate cancer and benign tissue

Trial Safety

Trial Design

1 Treatment Group

Screening (3D MRI)
1 of 1

Experimental Treatment

20 Total Participants · 1 Treatment Group

Primary Treatment: Magnetic Resonance Imaging · No Placebo Group · N/A

Screening (3D MRI)
Experimental Group · 1 Intervention: Magnetic Resonance Imaging · Intervention Types: Procedure
First Studied
Drug Approval Stage
How many patients have taken this drug
Magnetic Resonance Imaging
Completed Early Phase 1

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: through study completion, an average of 1 year

Who is running the clinical trial?

M.D. Anderson Cancer CenterLead Sponsor
2,805 Previous Clinical Trials
1,790,514 Total Patients Enrolled
89 Trials studying Prostate Cancer
27,515 Patients Enrolled for Prostate Cancer
Tharakeswara BathalaPrincipal InvestigatorM.D. Anderson Cancer Center
1 Previous Clinical Trials
258 Total Patients Enrolled
1 Trials studying Prostate Cancer
258 Patients Enrolled for Prostate Cancer

Eligibility Criteria

Age 18+ · Male Participants · 5 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Who else is applying?

What state do they live in?
What portion of applicants met pre-screening criteria?
Met criteria100.0%
What site did they apply to?
M D Anderson Cancer Center100.0%
How many prior treatments have patients received?